
Kairos Ventures
Description
Kairos Ventures is a Beverly Hills, California-based venture capital firm established in 2014 by Jim Demetriades, specializing in the commercialization of scientific discoveries originating from leading research institutions and universities. The firm positions itself at the forefront of deep technology and hard science innovation, aiming to bridge the gap between groundbreaking academic research and market-ready solutions. Their investment thesis is centered on identifying and nurturing intellectual property and businesses with significant disruptive potential across various scientific domains, including life sciences, physical sciences, AI, robotics, and quantum computing.
The firm primarily invests at the seed and Series A stages, providing crucial early-stage capital to nascent companies. Kairos Ventures typically deploys initial checks ranging from $1 million to $10 million, demonstrating a commitment to substantial early support for its portfolio companies. This strategic focus allows them to engage deeply with scientific founders and assist in the complex process of translating laboratory breakthroughs into viable commercial products. To date, Kairos Ventures has invested in over 70 companies, showcasing a broad and active portfolio across its target sectors.
With a robust financial backing, Kairos Ventures has successfully raised over $1 billion in capital, underscoring its significant presence in the deep tech investment landscape. This substantial capital base enables the firm to provide follow-on funding and support its portfolio companies through various growth phases. For instance, their recent Kairos Ventures Fund IV, L.P. closed with $300 million in 2023, further solidifying their capacity for new investments and continued support. Their long-term partnership approach emphasizes not just capital infusion but also strategic guidance and access to a network of industry experts, aiming to accelerate the development and market adoption of complex scientific innovations.
Investor Profile
Kairos Ventures has backed more than 58 startups, with 1 new investments in the last 12 months alone. The firm has led 20 rounds, about 34% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Typical check size: $1M – $10M.
Stage Focus
- Seed (38%)
- Series A (33%)
- Series Unknown (14%)
- Series B (9%)
- Series C (3%)
- Series D (2%)
- Debt Financing (2%)
Country Focus
- United States (98%)
- United Kingdom (2%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Manufacturing
- Pharmaceutical
- Medical Device
- Chemical
- Software
- Agriculture
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.